Skip to main content
Log in

Human pancreas-specific protein

A diagnostic and prognostic marker in acute pancreatitis and pancreas transplantation

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

Conclusion

Human pancreas-specific protein (hPASP) is a very sensitive reflector of the extent of pancreatic necrosis on the cellular level, and is of both diagnostic and prognostic value in acute pancreatitis. Furthermore, it allows the estimation of the severity of graft pancreatitis soon after simultaneous renal and pancreatic transplantation.

Background

Diagnosis of acute pancreatitis (AP) has been improved in the past 15 yr as new methods for the determination of specific pancreatic enzymes have been developed. However, these enzymes have no prognostic implications. In this prospective study, we evaluated the role of human pancreas-specific protein (hPASP) in comparison with pancreatic amylase and C-reactive protein (CRP) in acute pancreatitis and pancreas transplantation.

Patients and Methods

The study included 40 patients (22 female, 18 male; mean age 51 yr, range 22–88 yr) with AP and 7 patients (2 female, 5 male; mean age 37 yr, range 25–49 yr) with type I diabetes and renal insufficiency who underwent simultaneous kidney and pancreas transplantation. By means of contrast-enhanced computed tomography (CT) and/or intraoperative findings, patients were judged to have edematous-interstitial (AIP,n=20, mean age 55.2 yr, range 24–88 yr) or necrotizing pancreatitis (NP,n=20, mean age 46.3 yr, range 22–81 yr). Serum hPASP concentration was measured daily by a commercial radioimmunoassay technique. In 25 healthy subjects and in several control groups (35 patients with chronic pancreatitis, 20 patients with pancreatic carcinoma and 80 patients with different gastrointestinal diseases) a single blood specimen was taken at hospital admission for the determination of the normal range of hPASP and for specificity analysis.

Results

The upper normal value for hPASP in healthy subjects was found to be 52 ng/mL. Serum hPASP was elevated in all patients suffering from AP, with a median of 343 ng/mL (lower-upper quartile: 192–478 ng/mL) at hospital admission. In the daily serum monitoring with respect to the onset of symptoms, significantly higher hPASP levels were found in NP compared with AIP after day 2 (p<0.001). In patients with NP, peak values of hPASP correlated significantly with the extent of pancreatic necroses measured by contrast-enhanced CT-scanning, whereas CRP did not. Six patients of the transplantation group had the same serum hPASP course as AIP, with almost normal values on the third postoperative day. One patient had elevated levels throughout the observation period. This patient suffered from necrotizing graft pancreatitis, confirmed by relaparotomy, and died because of subsequent septic complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pousette Å, Fernstad R, Sköldefors H, Carlström K. A novel assay for pancreatic cellular damage: I. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein.Pancreas 1988; 3: 421–426.

    Article  PubMed  CAS  Google Scholar 

  2. Yamamoto K, Pousette Å, Phoebe Ch, et al. Isolation of a cDNA encoding a human serum mariner for acute pancreatitis.J Biol Chem 1992; 267: 2575–2581.

    PubMed  CAS  Google Scholar 

  3. Fernstad R, Pousette Å, Carlström K, Sköldefors H. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases.Pancreas 1990; 5: 42–49.

    Article  PubMed  CAS  Google Scholar 

  4. Pousette Å, Fernstad R, Sköldefors H, Carlström K. A novel assay for pancreatic cellular damage: II. High tissue specificity of a pancreatic protein.Pancreas 1988; 3: 642–645.

    PubMed  CAS  Google Scholar 

  5. Fernstad R, Sköldefors H, Pousette Å, et al. A novel assay for pancreatic cellular damage: Ill. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans.Pancreas 1989; 4: 44–52.

    Article  PubMed  CAS  Google Scholar 

  6. Fernstad R, Tydén G, Brattstrom CH, et al. Pancreas-specific: protein: New serum marker for graft rejection in pancreas-transplant recipients.Diabetes 1989; 38: 55, 56.

    PubMed  Google Scholar 

  7. Nordestgaard AG, Wilson SE, Russell AW. Correlation of serum amylase levels with pancreatic pathology and pancreatitis etiology.Pancreas 1988; 2: 159–162.

    Article  Google Scholar 

  8. Spechler SJ, Schimmel EH. Serum amylase in pancreatitis.Dig Dis Sci 1985; 30: 92, 93.

    Article  PubMed  CAS  Google Scholar 

  9. Uhl W, Malfertheiner P, Drosdat H, Martini M, Büchler M. Determination of pancreatic lipase by immunoactivation technology.Int J Pancreatol 1992; 3: 253–261.

    Article  Google Scholar 

  10. Chen CC, Wang SS, Chao Y, Lu CW, Lee SD, Tsai YT, Lo KJ. C-reactive protein and lactat dehydrogenase isoenzymes in the assessment of prognosis of acute pancreatitis.J Gastroenterol Hepatol 1992; 4: 363–366.

    Article  Google Scholar 

  11. Mayer AD, McMahon M, Bowen MJ, Cooper EH. C-reactive protein: an aid to assessment and monitoring of acute pancreatitis.J Clin Path 1984; 37: 207–211.

    Article  PubMed  CAS  Google Scholar 

  12. Block S, Maier W, Clausen C, Bittner R, Büchler M, Malfertheiner P, Beger HG. Identification of pancreas necrosis in severe acute pancreatitis: Imaging procedures versus clinical staging.Gut 1986; 27: 1035–1042.

    Article  PubMed  CAS  Google Scholar 

  13. Balthazar EJ. CT diagnosis and staging of acute pancreatitis.Rad Clin North Am 1989; 27: 19–37.

    CAS  Google Scholar 

  14. Koop H. Serum levels of pancreatic enzymes and their clinical significance, inThe Exocrine Pancreas, Clinics in Gastroenterology, Creutzfeld W (ed.), W. B. Saunders, London, Philadelphia, Toronto, 1984; pp. 739–762.

    Google Scholar 

  15. Steinberg WM. Predictors of severity of acute pancreatitis.Gastroenterol Clin North Am 1990; 19: 849–861.

    PubMed  CAS  Google Scholar 

  16. Büchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: results of a prospective study.Int J Pancreatol 1986; 1: 227–235.

    PubMed  Google Scholar 

  17. Büchler M. Objectivation of the severity of acute pancreatitis.Hepato-Gastroenterol 1991; 38: 101–108.

    Google Scholar 

  18. Isenmann R, Büchler MW, Uhl W, Malfertheiner P, Martini M, Beger HG. Pancreatic necrosis: an early finding in severe acute pancreatitis.Pancreas 1993; 8: 358–361.

    Article  PubMed  CAS  Google Scholar 

  19. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-Elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis.Pancreas 1991; 6: 253–259.

    Article  PubMed  CAS  Google Scholar 

  20. Nyberg G, Olausson M, Nordén G, et al. Pancreas-specific protein: Monitoring in pancreas transplantation.Transplant Proc 1991; 23: 1604, 1605.

    PubMed  CAS  Google Scholar 

  21. Fernstad R, Kylander Ch, Tsai L, Tydén G, Pousette Å. Isoforms of procarboxypeptidase B (pancreas-specific protein, PASP) in human serum, pancreatic tissue and juice.Scand J Clin Lab Invest 1993; 53: 9–17.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmid, S.W., Uhl, W., Steinle, A. et al. Human pancreas-specific protein. Int J Pancreatol 19, 165–170 (1996). https://doi.org/10.1007/BF02787364

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02787364

Key Words

Navigation